Scientific and practical workshop "Pressing issues associated with cervical cancer screening"
- Date of the news:
- Component:
- Subproject:
On August 12, 2016, a scientific workshop "Pressing issues associated with cervical cancer screening" was held at Lviv Oblast-level Cancer Facility.
Head physician of the Israeli LISOD Hospital, prof. Alla Borysivna Vinnytska, delivered a presentation on the importance of screening and topicality of vaccination against human papilloma virus (HPV).
"Unfortunately, a heart attack is considered to be prestigious, a stroke is considered to be fashionable, and oncology causes fear in people",- stated Alla Borysivna Vinnytska.
Thus, the effectiveness of screening in oncology is proven:
- Breast cancer (up to 35 - ultrasound, after 35-37 - mammography)
- Cervical cancer (cytological examination)
- Prostate cancer (after 45)
- Colorectal cancer (after 50 in women and men).
The effectiveness of cancer treatment is 85-100% dependent on its early detection.
It is the early detection of cancer that screening is aimed at, since in the availability of symptoms, early diagnosis is a means of pathologies identification.
Reduced mortality from certain types of oncological diseases is the outcome of screening.
Within the "Preventive oncology and the implementation of effective anti-tumor technologies in Lviv Oblast" Subproject, breast and cervical cancer screening is topical.
Breast cancer is the most common disease in women and the leading cause of death from cancer. Self-examination of the breast by women is important; however, its effectiveness is relative. Therefore, be aware that it is clinical breast examination by diagnostic ultrasound under the age of 35, and mammography after 35-40 years which are effective. For the sake of its highest efficiency, mammographic screening should be carried out by highly qualified professionals.
According to the American Cancer Institute, 98% of women are cured when breast cancer is detected at early stages.
All women after 21 (or after the onset of sexual debut) must undergo an annual examination by a gynecologist with having cytological smear taken, specifically cytological screening.
Due to mass, organized and regular cervical cancer screening, mortality rates have been reduced by 80% and 50% in Iceland and Finland over the past 20 years.
Cytological screening involves examination by a gynecologist annually; if over 3 consecutive years Pap test does not detect changes in cervical cells, then PAP test should be carried out one time in every 2-3 years until the age of 65. After 65, cytological examination may not be performed if the preliminary results were negative.
Modern science has proven link between cervical cancer and human papilloma virus (HPV). Vaccination is most appropriate for girls aged under 16 or until the onset of sexual debut; however, the effectiveness of vaccination of women already infected with HPV is also proven.
During the workshop, head affiliated specialist in gynaecologic oncology of the Health Care Department, Ms. Svitlana Struk, talked about "Cervical cancer screening in Lviv oblast and the practical steps of the 'Preventive oncology and the implementation of effective anti-tumor technologies' Subproject implementation.
Screening saves lives!
Foto
